Osvyrti 60 mg/1.0 ml, Injektionslösung in einer Fertigspritze

7680701010015 CH-70101 Injektionslösung

Associated product:

OSVYRTI 60 mg/1.0 ml sol inj ser prérempl 60 mg 1

No image available

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/09/2026
Patient information leaflet
Français
19/09/2026
Patient information leaflet
Italien
19/09/2026
Summary of Product Characteristics
Allemand
26/08/2026
Summary of Product Characteristics
Français
26/08/2026
Summary of Product Characteristics
Italien
26/08/2026

Detailed composition

Substance Quantity Type Category
denosumabum
60.0 MG Substance Wirkstoff (Principe actif)
polysorbatum 20
0.1 MG Substance HBESI
sorbitolum
46.0 MG Substance HBESI
acidum aceticum glaciale
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 206.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2026

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
70101
Drug name
Osvyrti, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
M05BX04
Authorization status
Z
Dispensing category
B
First authorization
30/04/2026
Authorization expiration date
29/04/2031
IT Number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Package details

Description (FR)
OSVYRTI 60 mg/1.0 ml sol inj ser prérempl 60 mg 1
Description (DE)
OSVYRTI 60 mg/1.0 ml Inj Lös Fertigspr 60 mg 1 Stk
Market launch
05/06/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data